These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1805447

  • 1. Inhibitory effect of heparin cofactor II on thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells.
    Hayashi T, Kaji T, Hayakawa Y, Niiya K, Sakamoto M, Sakuragawa N.
    Thromb Res; 1991 Nov 01; 64(3):321-30. PubMed ID: 1805447
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
    Liaw PC, Austin RC, Fredenburgh JC, Stafford AR, Weitz JI.
    J Biol Chem; 1999 Sep 24; 274(39):27597-604. PubMed ID: 10488098
    [Abstract] [Full Text] [Related]

  • 7. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
    Blinder MA, Tollefsen DM.
    J Biol Chem; 1990 Jan 05; 265(1):286-91. PubMed ID: 2104620
    [Abstract] [Full Text] [Related]

  • 8. Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wall.
    Pasche B, Swedenborg J, Frebelius S, Olsson P.
    Thromb Res; 1991 Jun 01; 62(5):409-19. PubMed ID: 1896960
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
    Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA.
    Ann N Y Acad Sci; 1989 Jun 01; 556():123-31. PubMed ID: 2525356
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
    Sheehan JP, Tollefsen DM, Sadler JE.
    J Biol Chem; 1994 Dec 30; 269(52):32747-51. PubMed ID: 7806495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate.
    Kaji T, Ejiri N, Hayakawa Y, Hayashi T, Sakuragawa N.
    Thromb Res; 1990 Jul 15; 59(2):269-77. PubMed ID: 2122537
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T, Parkinson JF, Sié P, Bang NU, Müller-Berghaus G, Preissner KT.
    Eur J Biochem; 1991 Jun 15; 198(3):563-70. PubMed ID: 1646716
    [Abstract] [Full Text] [Related]

  • 20. Affinity chromatography of sulphated polysaccharides separately fractionated on antithrombin III and heparin cofactor II immobilized on concanavalin A--sepharose.
    Sinniger V, Tapon-Bretaudière J, Millien C, Muller D, Jozefonvicz J, Fischer AM.
    J Chromatogr; 1993 Jun 02; 615(2):215-23. PubMed ID: 8335699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.